What is the pathophysiology of a vesicovaginal fistula following hysterectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Vesicovaginal Fistula After Hysterectomy

Vesicovaginal fistulas following hysterectomy develop primarily through unrecognized bladder injury during surgery, leading to urinary extravasation that subsequently drains through the vaginal cuff, creating an abnormal communication between the bladder and vagina. 1

Primary Mechanism: Unrecognized Bladder Injury

The fundamental pathophysiologic process involves:

  • Direct bladder trauma during dissection that goes unrecognized intraoperatively, resulting in urinary extravasation into surrounding tissues 1
  • Formation of a urinoma (collection of extravasated urine) in the postoperative period 1
  • Drainage of the urinoma into the dependent vaginal cuff, which is typically left open or incompletely closed, establishing the fistulous tract 1

Vascular Compromise and Tissue Necrosis

Beyond direct injury, the pathophysiology involves:

  • Ischemic tissue damage from excessive bladder mobilization, cautery injury, or suture placement that compromises blood supply to the bladder wall 2, 3
  • Tissue necrosis developing over 7-14 days postoperatively as devitalized tissue breaks down 2
  • Progressive tissue breakdown creating the fistulous communication, typically manifesting 10-14 days after surgery 4

Severity-Dependent Risk

The extent of bladder injury directly correlates with fistula formation:

  • AAST Grade V bladder injuries carry a 93-fold increased risk of VVF development compared to lower-grade injuries (OR 93.00; 95% CI 10.30-838.92) 5
  • Complex injuries involving larger defects, multiple sites, or trigone involvement have substantially higher fistula rates 5

Clinical Indicators of Evolving Fistula

Specific postoperative findings suggest ongoing fistula development:

  • Severe abdominal pain and distension occurring postoperatively, indicating urinary extravasation 1
  • Paralytic ileus from peritoneal irritation by extravasated urine 1
  • Hematuria and bladder irritability symptoms reflecting bladder injury 1
  • Prolonged fever and leukocytosis from inflammatory response to urine in tissues 1

Contributing Surgical Factors

Specific operative conditions increase risk:

  • Uteri weighing >250 grams (83% of VVF cases vs 36% of uncomplicated cystotomies; P=0.03) 5
  • Prolonged operative time (mean 317 minutes in VVF cases vs 208 minutes without; P=0.02) 5
  • Concurrent ureteral injury (33% of VVF cases vs 1% without; P=0.009) 5

Radiation-Related Pathophysiology

When radiation is involved:

  • Vascular endothelial cell damage develops with latency of 1-25 years, causing progressive ischemia 6
  • Bladder wall fibrosis and poor vascularity impair healing and predispose to fistula formation after any subsequent trauma or surgery 6
  • Vesicovaginal fistulas from radiation may occur spontaneously or after minor trauma due to compromised tissue integrity 6

Key Pathophysiologic Distinction

The critical difference between fistulas that heal with conservative management versus those requiring surgery relates to whether the initial injury was recognized and properly repaired intraoperatively 1, 3. Unrecognized injuries allow continued urinary extravasation, preventing spontaneous healing and necessitating the urinoma-to-vaginal-cuff drainage pathway that establishes the fistula 1.

References

Research

Prevention of the development of a vesicovaginal fistula.

Surgery, gynecology & obstetrics, 1988

Research

Vesicovaginal fistula.

Current urology reports, 2002

Research

Vesicovaginal fistula.

Obstetrical & gynecological survey, 1994

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.